4.5 Review

Phloroglucinol compounds of therapeutic interest: global patent and technology status

Journal

EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 19, Issue 6, Pages 847-866

Publisher

INFORMA HEALTHCARE
DOI: 10.1517/13543770902916614

Keywords

anticancer; anti-depressant; anti-microbial; anti-protozoal; anti-spasmodic; anti-viral; dermatology; hyperforin; pharmaceutical compositions; phloroglucinol

Funding

  1. NIPER
  2. HOD
  3. Department of Natural Products

Ask authors/readers for more resources

Background: Phloroglucinol compounds, both synthetic as well as natural, have shown a vast array of biological activities. There are a wide range of applications of phloroglucinol compounds in pharmaceuticals, cosmetics, textiles, paints and dyeing industries. Although many of the phloroglucinols have shown promising results in various biological assays, very few have reached clinics. Objective: To compile the patented information on various therapeutically active phloroglucinol molecules, so that technologies used in isolation and activity assessment of these compounds could be unearthed and the compiled information be utilized for further development of these molecules. Methods: The European Patent Office database (official website: espacenet.com) was searched with a keyword phloroglucinol. In addition, patents were searched using names of compounds listed in our previous review. Conclusions: This class holds potential for development of molecules in various therapeutic areas. There exist a number of patents on preparations that have phloroglucinol compounds as active ingredient(s). Many such preparations have been tested in vitro and/or in vivo for their efficacy and proven to be active and non-toxic. Commercialization of existing technology on phloroglucinol molecules can yield fruitful results.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available